← Leaderboards
Marek-Marsel M Mesulam
Northwestern University
$28,227,526
Attributed
$41,083,049
Total exposure
28
Grants
17
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $9.8M · FY2005–25$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$82,513,237 · 30
By mechanism
P30$30,995,295 · 9
R01$26,404,114 · 6
U19$23,636,707 · 3
R56$1,380,437 · 1
M01$96,684 · 11
Top collaborators
- Emily J Rogalski31 shared
- Changiz Geula28 shared
- Tamar D Gefen1 shared
Most similar at Northwestern University
Same institution · by research overlap
- Sandra Weintraub$24,136,735
- Darby Morhardt$3,999,277
- Tamar D Gefen$2,987,587
- Robert J Vassar$28,822,218
- Angela Christine Roberts$7,228,064
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposS DiseaseCollaborationsResearch PersonnelNeuropathologyDementiaBrainFundingBiometryCohortProgramsStructureResourcesCognitiveBaseNeuropsychologyAutopsyInvestigationUniversitiesAgingDesignImageMolecularPrimary Progressive Aphasia
Grant awards (134)
Study to Uncover Pathways to Exceptional Cognitive Resilience in Aging (SUPERAging)$2,858,489
U19 · FY2025 · AG
Core-003$2,070,423
U19 · FY2025 · AG
ASYMMETRIC NEURODEGENERATION AND LANGUAGE IN PRIMARY PROGRESSIVE APHASIA$2,058,335
R01 · FY2025 · AG · contact PI
Admin-Core-003$788,066
U19 · FY2025 · AG
Anatomic, Pathologic, and Molecular Signatures of FTLD-TDP type C$786,632
R01 · FY2025 · AG
Cognitive SuperAging: A model to explore resilience and resistance to aging and Alzheimers disease$673,808
R01 · FY2025 · AG
Study to Uncover Pathways to Exceptional Cognitive Resilience in Aging (SUPERAging)$403,457
U19 · FY2025 · AG
Study to Uncover Pathways to Exceptional Cognitive Resilience in Aging (SUPERAging)$105,096
U19 · FY2025 · AG
Study to Uncover Pathways to Exceptional Cognitive Resilience in Aging (SUPERAging)$83,006
U19 · FY2025 · AG
Study to Uncover Pathways to Exceptional Cognitive Resilience in Aging (SUPERAging)$3,562,822
U19 · FY2024 · AG
ASYMMETRIC NEURODEGENERATION AND LANGUAGE IN PRIMARY PROGRESSIVE APHASIA$2,100,342
R01 · FY2024 · AG · contact PI
Core-003$737,827
U19 · FY2024 · AG
Admin-Core-003$381,203
U19 · FY2024 · AG
Study to Uncover Pathways to Exceptional Cognitive Resilience in Aging (SUPERAging)$2,660,591
U19 · FY2023 · AG
ASYMMETRIC NEURODEGENERATION AND LANGUAGE IN PRIMARY PROGRESSIVE APHASIA$2,057,942
R01 · FY2023 · AG · contact PI
Study to Uncover Pathways to Exceptional Cognitive Resilience in Aging (SUPERAging)$1,279,463
U19 · FY2023 · AG
Cognitive SuperAging: A model to explore resilience and resistance to aging and Alzheimers disease$747,866
R01 · FY2023 · AG
Core-003$404,003
U19 · FY2023 · AG
Admin-Core-003$200,071
U19 · FY2023 · AG
Study to Uncover Pathways to Exceptional Cognitive Resilience in Aging (SUPERAging)$3,972,149
U19 · FY2022 · AG
ASYMMETRIC NEURODEGENERATION AND LANGUAGE IN PRIMARY PROGRESSIVE APHASIA$2,089,742
R01 · FY2022 · AG · contact PI
Cognitive SuperAging: A model to explore resilience and resistance to aging and Alzheimers disease$751,796
R01 · FY2022 · AG
Study to Uncover Pathways to Exceptional Cognitive Resilience in Aging (SUPERAging)$4,130,041
U19 · FY2021 · AG
Cognitive SuperAging: A model to explore resilience and resistance to aging and Alzheimers disease$748,297
R01 · FY2021 · AG
Language in Primary Progressive Aphasia$606,614
R01 · FY2021 · DC · contact PI
Cognitive SuperAging: A model to explore resilience and resistance to aging and Alzheimers disease$759,391
R01 · FY2020 · AG
Language in Primary Progressive Aphasia$620,708
R01 · FY2020 · DC · contact PI
Core A: Administrative Core$352,056
P30 · FY2020 · AG · contact PI
Core F: Research Education Component (RL5)$74,067
P30 · FY2020 · AG · contact PI
Exceptional Cognitive Aging: Neuropsychologic, Anatomic and Pathologic Correlates$1,380,437
R56 · FY2019 · AG
Language in Primary Progressive Aphasia$630,588
R01 · FY2019 · DC · contact PI
Core A: Administrative Core$352,056
P30 · FY2019 · AG · contact PI
Exceptional Cognitive Aging: Neuropsychologic, Anatomic and Pathologic Correlates$351,038
R01 · FY2019 · AG
Core F: Research Education Component (RL5)$74,067
P30 · FY2019 · AG · contact PI
Alzheimer's Disease Core Center$694,340
P30 · FY2018 · AG · contact PI
Language in Primary Progressive Aphasia$647,783
R01 · FY2018 · DC · contact PI
Exceptional Cognitive Aging: Neuropsychologic, Anatomic and Pathologic Correlates$444,140
R01 · FY2018 · AG
Core A: Administrative Core$413,139
P30 · FY2018 · AG · contact PI
Administrative Supplement to the Alzheimer's Disease Core Center - Neuropathology Core$100,000
P30 · FY2018 · AG · contact PI
Core F: Research Education Component (RL5)$74,067
P30 · FY2018 · AG · contact PI
Alzheimer's Disease Core Center$1,721,501
P30 · FY2017 · AG · contact PI
Language in Primary Progressive Aphasia$660,025
R01 · FY2017 · DC · contact PI
Exceptional Cognitive Aging: Neuropsychologic, Anatomic and Pathologic Correlates$444,140
R01 · FY2017 · AG
Core A: Administrative Core$352,056
P30 · FY2017 · AG · contact PI
Alzheimer's Disease Core Center$159,110
P30 · FY2017 · AG · contact PI
Core F: Research Education Component (RL5)$74,067
P30 · FY2017 · AG · contact PI
Alzheimer's Disease Core Center$1,720,585
P30 · FY2016 · AG · contact PI
Language in Primary Progressive Aphasia$566,128
R01 · FY2016 · DC · contact PI
Exceptional Cognitive Aging: Neuropsychologic, Anatomic and Pathologic Correlates$467,319
R01 · FY2016 · AG
Core A: Administrative Core$351,869
P30 · FY2016 · AG · contact PI
Core F: Research Education Component (RL5)$74,027
P30 · FY2016 · AG · contact PI
Alzheimer's Disease Core Center$1,227,252
P30 · FY2015 · AG · contact PI
Language in Primary Progressive Aphasia$610,886
R01 · FY2015 · DC · contact PI
Exceptional Cognitive Aging: Neuropsychologic, Anatomic and Pathologic Correlates$456,514
R01 · FY2015 · AG
Clinical Core$405,234
P30 · FY2015 · AG · contact PI
Administrative Core$249,062
P30 · FY2015 · AG · contact PI
Neuropathology Core$220,984
P30 · FY2015 · AG · contact PI
Education Core$188,208
P30 · FY2015 · AG · contact PI
Data Management and Statistics Core$163,764
P30 · FY2015 · AG · contact PI
Alzheimer's Disease Core Center$1,272,677
P30 · FY2014 · AG · contact PI
Language in Primary Progressive Aphasia$622,995
R01 · FY2014 · DC · contact PI
Exceptional Cognitive Aging: Neuropsychologic, Anatomic and Pathologic Correlates$460,543
R01 · FY2014 · AG
Clinical Core$419,400
P30 · FY2014 · AG · contact PI
Administrative Core$260,451
P30 · FY2014 · AG · contact PI
Neuropathology Core$229,671
P30 · FY2014 · AG · contact PI
Education Core$194,245
P30 · FY2014 · AG · contact PI
Data Management and Statistics Core$168,910
P30 · FY2014 · AG · contact PI
Alzheimer's Disease Core Center$1,197,485
P30 · FY2013 · AG · contact PI
Language in Primary Progressive Aphasia$591,846
R01 · FY2013 · DC · contact PI
Clinical Core$393,828
P30 · FY2013 · AG · contact PI
Administrative Core$247,124
P30 · FY2013 · AG · contact PI
Neuropathology Core$216,582
P30 · FY2013 · AG · contact PI
Education Core$181,889
P30 · FY2013 · AG · contact PI
Data Management and Statistics Core$158,062
P30 · FY2013 · AG · contact PI
Alzheimer's Disease Core Center$1,288,062
P30 · FY2012 · AG · contact PI
Language in Primary Progressive Aphasia$609,464
R01 · FY2012 · DC · contact PI
Clinical Core$422,756
P30 · FY2012 · AG · contact PI
Administrative Core$268,047
P30 · FY2012 · AG · contact PI
Neuropathology Core$233,488
P30 · FY2012 · AG · contact PI
Education Core$194,695
P30 · FY2012 · AG · contact PI
Data Management and Statistics Core$169,076
P30 · FY2012 · AG · contact PI
Alzheimer's Disease Core Center$1,295,353
P30 · FY2011 · AG · contact PI
Clinical Core$424,484
P30 · FY2011 · AG · contact PI
Language in Primary Progressive Aphasia$332,481
R01 · FY2011 · DC · contact PI
Administrative Core$271,958
P30 · FY2011 · AG · contact PI
Neuropathology Core$234,823
P30 · FY2011 · AG · contact PI
Education Core$194,926
P30 · FY2011 · AG · contact PI
Data Management and Statistics Core$169,162
P30 · FY2011 · AG · contact PI
Alzheimer's Disease Core Center$1,149,148
P30 · FY2010 · AG · contact PI
Language in Primary Progressive Aphasia$515,547
R01 · FY2010 · DC · contact PI
Alzheimer's Disease Core Center$1,132,627
P30 · FY2009 · AG · contact PI
Language in Primary Progressive Aphasia$514,431
R01 · FY2009 · DC · contact PI
Language in Primary Progressive Aphasia$206,270
R01 · FY2009 · DC · contact PI
Alzheimer's Disease Core Center$1,103,208
P30 · FY2008 · AG · contact PI
Language in Primary Progressive Aphasia$439,625
R01 · FY2008 · DC · contact PI
Neurology of Attention and Neglect-A Network Approach$326,315
R01 · FY2008 · NS · contact PI
Alzheimer's Disease Core Center$75,500
P30 · FY2008 · AG · contact PI
Alzheimer's Disease Core Center$1,094,830
P30 · FY2007 · AG · contact PI
Language in Primary Progressive Aphasia$371,919
R01 · FY2007 · DC · contact PI
Neurology of Attention and Neglect-A Network Approach$326,315
R01 · FY2007 · NS · contact PI
ALZHEIMER'S DISEASE NEUROIMAGING INITIATIVE$20,564
M01 · FY2007 · RR · contact PI
ADCS/NIA PROTOCOL ACD-016: HIGH DOSE SUPPLEMENTS AND ALZHEIMER'S DISEASE$7,311
M01 · FY2007 · RR · contact PI
ADCS/NIA PROTOCOL ACD-015: SIMVASTATIN TO SLOW THE PROGRESSION OF ALZHEIMER'S$3,656
M01 · FY2007 · RR · contact PI
Alzheimer's Disease Core Center$1,097,045
P30 · FY2006 · AG · contact PI
Neurology of Attention and Neglect-A Network Approach$336,061
R01 · FY2006 · NS · contact PI
ADMINISTRATIVE CORE$147,921
P30 · FY2006 · AG · contact PI
ADCS/NIA PROTOCOL ACD-016: HIGH DOSE SUPPLEMENTS AND ALZHEIMER'S DISEASE$11,825
M01 · FY2006 · RR · contact PI
ADCS/NIA PROTOCOL ACD-015: SIMVASTATIN TO SLOW THE PROGRESSION OF ALZHEIMER'S$8,869
M01 · FY2006 · RR · contact PI
ALZHEIMER'S DISEASE NEUROIMAGING INITIATIVE$5,490
M01 · FY2006 · RR · contact PI
Alzheimer's Disease Core Center$1,081,872
P30 · FY2005 · AG
Neurology of Attention and Neglect-A Network Approach$344,149
R01 · FY2005 · NS
Alzheimer's Disease Core Center$38,640
P30 · FY2005 · AG
ADCS/NIA PROTOCOL ADC-015: SIMVASTATIN TO SLOW THE PROGRESSION OF ALZHEIMER'S$7,367
M01 · FY2005 · RR
DOSE-DEPENDENT EFFECTS OF BROMOCRIPTINE ON INATTENTION$5,986
M01 · FY2005 · RR
ADCS/NIA PROTOCOL ADC-016: HIGH DOSE SUPPLEMENTS AND ALZHEIMER'S DISEASE$4,144
M01 · FY2005 · RR
Alzheimer's Disease Core Center$1,052,523
P30 · FY2004 · AG
Neurology of Attention and Neglect-A Network Approach$344,149
R01 · FY2004 · NS
Dose-Dependent Effects of Bromocriptine on Inattention$10,410
M01 · FY2004 · RR
ADCS/NIA Protocol ACD-015: Simvastatin to Slow the Progression of Alzheimer's$5,206
M01 · FY2004 · RR
Vitamin E and Donepezil to Delay the Progression from MCI to Alzheimer's Disease$3,254
M01 · FY2004 · RR
ADCS/NIA Protocol ACD-016: High Dose Supplements and Alzheimer's Disease$2,602
M01 · FY2004 · RR
Alzheimer's Disease Core Center$2,000
P30 · FY2004 · AG
Alzheimer's Disease Core Center$1,025,949
P30 · FY2003 · AG
Alzheimer's Disease Core Center$997,485
P30 · FY2002 · AG
Alzheimer's Disease Core Center$971,924
P30 · FY2001 · AG
NEUROLOGY OF ATTENTION AND NEGLECT --A NETWORK APPROACH$346,899
R01 · FY2001 · NS
NEUROLOGY OF ATTENTION AND NEGLECT --A NETWORK APPROACH$50,000
R01 · FY2001 · NS
ROPINIROLE IN TREATMENT OF UNILATERAL INATTENTION AFTER STROKE$0
M01 · FY2001 · RR
VITAMIN E AND DONEPEZIL HCl (ARICEPT) TO DELAY PROGRESSION TO ALZHEIMER'S DISEASE$0
M01 · FY2001 · RR
ALZHEIMERS DISEASE CORE CENTER$875,958
P30 · FY2000 · AG
NEUROLOGY OF ATTENTION AND NEGLECT --A NETWORK APPROACH$340,071
R01 · FY2000 · NS
NEUROLOGY OF ATTENTION AND NEGLECT --A NETWORK APPROACH$45,000
R01 · FY2000 · NS
VITAMIN E AND DONEPEZIL HCl (ARICEPT) TO DELAY PROGRESSION TO ALZHEIMER'S DISEASE$0
M01 · FY2000 · RR
ROPINIROLE IN TREATMENT OF UNILATERAL INATTENTION AFTER STROKE$0
M01 · FY2000 · RR